Ranbaxy Laboratories

Headquarters in India

Ranbaxy Laboratories website: http://www.ranbaxy.com

 

🔎 Run a search for “Ranbaxy Laboratories”

Get RSS feed of these results

All stories

Article
9 August 2007

AIDS drugs fiasco a tale of red tape [Canada]

Author: Amir Attaran, Professor, Institute of Population Health, University of Ottawa

As a professor of public health and law, I want to comment on Apotex's plan to sell its three-in-one AIDS medicine to Rwanda. Canada is not the best country to meet Rwanda's medicine needs, and if Apotex made the sale, it would be to Rwanda's profound...

Read more

Story
8 August 2007

Glaxo agrees to generic production of AIDS drugs for Rwanda by Apotex in Canada

See full story

Article
1 August 2007

The business of ethics remixed [India]

Author: Sudhir K Sinha, vice president, Group CSR/Reliance ADA, in Hardnews [India]

Corporate Social Responsibility (CSR) is a highly misunderstood and misinterpreted term in India...Some Indian companies believe that merely complying with laws and regulations fulfills their need for social responsibility...A responsible corporate...

Read more

Article
5 June 2007

India’s special economic zones - An ethics black hole

Author: Rajesh Chhabara, Ethical Corporation

...new regulations will allow developers to buy land directly from farmers for special economic zones...Human rights groups are outraged by the large-scale displacements and loss of livelihoods that the SEZs will cause. ..More than 86,000 hectares of...

Read more

Article
31 May 2007

Boehringer offers HIV drug without patents

Author: Bhuma Shrivastava, Mint [India]

...Boehringer Ingelheim has decided not to enforce patents on its anti-HIV drug, Nevirapine, in 78 low-income African and Asian countries...In a statement on its website, Boehringer says it will issue “short, non-assert declarations”, or licences, to...

Read more

Article
15 February 2007

It’s patent vs patient in AIDS fight [India]

Author: Noemie Bisserbe, Economic Times [India]

NGOs...are fighting pharma MNCs [multinationals] trying to patent their anti-AIDS drugs in India. So far, 12 anti-AIDS drugs for which patents are being sought by pharma MNCs [including GlaxoSmithKline, Boehringer Ingelheim, Gilead Sciences, Abbott...

Read more

Article
7 February 2007

India and the Drug Patent Wars

Author: Roger Bate, Health Policy Outlook, American Enterprise Institute

According to international medical journals and press coverage of the [Novartis] case, a U.S.-backed pharmaceutical giant is leading an assault on India to prevent the poorest from receiving lifesaving drugs... The reality…is far more complex.....

Read more

Article
3 February 2007
+ Français - Hide

Author: Philippe Rivière, Le Monde Diplomatique

le 30 janvier, le ministre de la santé, M. Mongkol na Songkla, a signé le décret qui lui permet de prendre des licences obligatoires sur le Kaletra (un traitement anti-VIH) du laboratoire américain Abbot et le Plavix, un anticoagulant du laboratoire...

Read more

Story
30 November 2006

Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to as low as $60/year for poor countries ahead of World AIDS Day under deal with Clinton Foundation

See full story

Article
30 November 2006

Cipla, Ranbaxy To Cut Pediatric Antiretroviral Drug Prices Ahead of World AIDS Day Under Deal With Clinton Foundation

Author: Kaiser Network Daily Reports [USA]

Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently...

Read more